Transcranial magnetic stimulation in obsessive compulsive disorder: a double-blind, cross over, placebo-controlled trial

被引：2
|
作者：
Ziblak, A. [1 ]
Tumkaya, S. [1 ]
Kashyap, H. [2 ]
机构：
[1] Pamukkale Univ, Psychiat, Denizli, Turkey
[2] NIMHANS, Clin Psychol, Bengaluru, India
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.euroneuro.2019.12.099
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.402
引用
收藏
页码：S75 / S76
页数：3
相关论文
共 50 条
  • [11] Treatment of obsessive-compulsive disorder with fluvoxamine: A multicentre, double-blind, placebo-controlled trial
    Goodman, WK
    Kozak, MJ
    Liebowitz, M
    White, KL
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 (01) : 21 - 29
  • [12] Double-blind, placebo-controlled trial of topiramate augmentation in the treatment of obsessive-compulsive disorder
    Berlin, Heather A.
    Koran, Lorrin M.
    Jenike, Michael A.
    Shapira, Nathan A.
    Chaplin, William
    Pallanti, Stefano
    Hollander, Eric
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 170S - 170S
  • [13] Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial
    Mowla, Arash
    Ghaedsharaf, Mehrnoosh
    CNS SPECTRUMS, 2020, 25 (04) : 552 - 556
  • [14] Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial
    Noorbala, AA
    Hosseini, SH
    Mohammadi, MR
    Akhondzadeh, S
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (02) : 155 - 159
  • [15] Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
    Afshar, Hamid
    Akuchekian, Shahla
    Mahaky, Behzad
    Zarean, Elham
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (10): : 976 - 981
  • [16] Efficacy of accelerated deep transcranial magnetic stimulation wi•th double cone coi•l in obsessive-compulsive disorder: A double-blind, placebo-controlled study
    Ozer, Ufuk
    Yucens, Bengu
    Tumkaya, Selim
    JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 171 : 325 - 331
  • [17] Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder
    Berlin, Heather A.
    Koran, Lorrin M.
    Jenike, Michael A.
    Shapira, Nathan A.
    Chaplin, William
    Pallanti, Stefano
    Hollander, Eric
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (05) : 716 - 721
  • [18] A double-blind, placebo-controlled trial of folic acid addition in fluoxetine for treatment of obsessive-compulsive disorder
    Tural, O
    Corapçioglu, A
    Bosgelmez, S
    Köroglu, G
    Duman, C
    Önder, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S307 - S307
  • [19] Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial
    Farnia, Vahid
    Gharehbaghi, Haniyeh
    Alikhani, Mostafa
    Almasi, Afshin
    Golshani, Sanobar
    Tatari, Faeze
    Davarinejad, Omran
    Salemi, Safora
    Bahmani, Dena Sadeghi
    Holsboer-Trachsler, Edith
    Brand, Serge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 137 - 143
  • [20] A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder
    Shapira, NA
    Ward, HE
    Mandoki, M
    Murphy, TK
    Yang, MC
    Blier, P
    Goodman, WK
    BIOLOGICAL PSYCHIATRY, 2004, 55 (05) : 553 - 555
12345